Yan Wei, Luo Xue, Gao Qing-Jun, Chen Bing-Feng, Ye Hui
Department of Thyroid Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, People's Republic of China.
Guizhou Medical University, Guiyang, 550001, People's Republic of China.
Diabetes Metab Syndr Obes. 2024 May 13;17:2013-2019. doi: 10.2147/DMSO.S453468. eCollection 2024.
To analyze the correlation between body mass index (BMI) and clinicopathological factors of papillary thyroid cancer (PTC).
The clinical data of patients with PCT who were hospitalized in the Department of Thyroid Surgery of the Affiliated Hospital of Guizhou Medical University from March 2023 to September 2023 were retrospectively collected, including age, gender, height, weight, BMI, v-raf murine sarcoma viral oncogene homolog B () gene mutation, tumor size, multifocus, Hashimoto's thyroiditis, lymph node metastasis and other clinicopathological factors. According to the World Health Organization (WHO) definition for Asian population, BMI≥25kg/m was obese group, 23≤BMI≤24.9kg/m was overweight group, 18.5≤BMI≤22.9kg/m was normal weight group, and BMI≤18.5kg/m was low weight group. The clinicopathological factors of overweight and obese patients with PTC were analyzed.
A total of 164 PTC patients were included, with an average BMI of (24.44±3.57) kg/m. Age of overweight and obese PTC patients (=1.978, =0.083); Gender of overweight and obese PTC patients ( value: 11.570, =0.004); Tumor size in overweight and obese PTC patients (=0.894, =0.411); gene mutation in overweight and obese PTC patients ( value: 1.452, =0.623); Multifocal lesions were found in overweight and obese patients ( value: 1.653, =0.201). Hashimoto's thyroiditis was found in overweight and obese PTC patients ( value: 1.147, =0.298). Overweight and obese patients with PTC had lymph node metastasis ( value: 1.690, =0.251).
Overweight and obesity in PTC patients are correlated with male, but not with age, tumor size, mutation, multifocality, Hashimoto's thyroiditis and lymph node metastasis.
分析体重指数(BMI)与甲状腺乳头状癌(PTC)临床病理因素之间的相关性。
回顾性收集2023年3月至2023年9月在贵州医科大学附属医院甲状腺外科住院的PTC患者的临床资料,包括年龄、性别、身高、体重、BMI、v-raf鼠肉瘤病毒癌基因同源物B()基因突变、肿瘤大小、多灶性、桥本甲状腺炎、淋巴结转移等临床病理因素。根据世界卫生组织(WHO)对亚洲人群的定义,BMI≥25kg/m为肥胖组,23≤BMI≤24.9kg/m为超重组,18.5≤BMI≤22.9kg/m为正常体重组,BMI≤18.5kg/m为低体重组。分析PTC超重和肥胖患者的临床病理因素。
共纳入164例PTC患者,平均BMI为(24.44±3.57)kg/m。超重和肥胖PTC患者的年龄(=1.978,=0.083);超重和肥胖PTC患者的性别(值:11.570,=0.004);超重和肥胖PTC患者的肿瘤大小(=0.894,=0.411);超重和肥胖PTC患者的基因突变(值:1.452,=0.623);超重和肥胖患者发现多灶性病变(值:1.653,=0.201)。超重和肥胖PTC患者发现桥本甲状腺炎(值:1.147,=0.298)。PTC超重和肥胖患者有淋巴结转移(值:1.690,=0.251)。
PTC患者超重和肥胖与男性相关,但与年龄、肿瘤大小、突变、多灶性、桥本甲状腺炎和淋巴结转移无关。